These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 3093447

  • 1. In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1986 Aug; 18(2):159-62. PubMed ID: 3093447
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    Chemotherapy; 1986 Aug; 32(6):506-14. PubMed ID: 3100147
    [Abstract] [Full Text] [Related]

  • 3. Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria.
    Bassetti M, Dembry LM, Farrel PA, Callan DA, Andriole VT.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):143-8. PubMed ID: 11750168
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Gooch G, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
    [Abstract] [Full Text] [Related]

  • 6. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
    Eliopoulos GM, Reiszner E, Moellering RC.
    Antimicrob Agents Chemother; 1985 Jan; 27(1):28-32. PubMed ID: 3845792
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.
    Bassetti M, Dembry LM, Farrel PA, Callan DA, Andriole VT.
    Antimicrob Agents Chemother; 2002 Jan; 46(1):234-8. PubMed ID: 11751142
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates.
    Fernandes CJ, Wilson RD, Ackerman VP.
    Chemotherapy; 1988 Jan; 34(3):216-28. PubMed ID: 3416660
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of amifloxacin and two of its metabolites.
    Venezia RA, Prymas LA, Shayegani A, Yocum DM.
    Antimicrob Agents Chemother; 1989 May; 33(5):762-6. PubMed ID: 2751287
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients.
    Rolston KV, Ho DH, LeBlanc B, Bodey GP.
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):681-3. PubMed ID: 3143584
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Oct; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
    Rolston KV, Nguyen H, Messer M, LeBlanc B, Ho DH, Bodey GP.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2263-6. PubMed ID: 2127348
    [Abstract] [Full Text] [Related]

  • 14. In-vitro activity of temafloxacin for gram-positive pathogens.
    Bille J, Glauser MP.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():9-14. PubMed ID: 1664835
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ertapenem against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc BM, Streeter H, Ho DH.
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):219-23. PubMed ID: 12106955
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX, Neu HC.
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of cefpirome (HR 810) against gram-positive isolates from cancer patients.
    Rolston KV, Bodey GP.
    Infection; 1986 Jun; 14(3):139-41. PubMed ID: 3733227
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]

  • 20. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
    Matsuzaki K, Watabe E, Yoshimori K, Shikano M, Sato Y, Hasegawa M, Kobayashi I.
    Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.